Temporomandibular disorders (TMDs) comprise a heterogeneous set of conditions affecting the TMJ and surrounding musculature, with common symptoms including pain at rest and/or during jaw function, limited range of motion, and TMJ noises such as clicking, popping, and crepitus. Many conditions may spontaneously resolve or respond to conservative measures including NSAIDs, soft diet, jaw rest, moist heat, steroids, physical therapy, splints, muscle relaxants, and/or antidepressants.
Clinical guidance from professional organizations (AADOCR, AAOMS) recommends initiating care with the most conservative, reversible, evidence-based therapies and reserving invasive or irreversible procedures for cases that fail conservative management or meet specified criteria.
Procedural descriptions in the policy: Arthrocentesis (lavage) is a minimally invasive irrigation of the joint to remove inflammatory mediators or adhesions and improve mobility. Occlusal splints (stabilization or mandibular repositioning appliances) are intended to reduce clenching/bruxism and reposition the jaw. Myofascial trigger point management includes dry needling or injections (local anesthetic, corticosteroid, dextrose, or saline) to relax muscle fibers and break the pain–tension cycle. Jaw mobility devices (e.g., TheraBite, Jaw Dynasplint, OraStretch, Therapacer) provide passive prolonged stretching for mandibular hypomobility. Epigenetic appliances are intraoral devices similar to retainers that purportedly apply pressure overnight to stimulate bone remodeling; the policy notes a lack of quality evidence supporting their efficacy.
The policy explicitly lists arthrocentesis, intra-articular corticosteroid injections, trigger point injections, physical therapy, and occlusal splints as medically necessary non-surgical services, while identifying biofeedback, jaw mobility mechanical stretching devices, multiple occlusal splints, and epigenetic appliances as unproven and not medically necessary.